Price $46.90 |
Market Cap
6.34B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
15.2
|
P/B
24.01
|
P/S
13.25
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
22.9
|
Op. Cash Flow
288.9K
|
FCF
1.9
|
|
Op. Margin
63.80%
|
Net Margin
92.20%
|
ROE
202.60%
|
ROI
38.10%
|
|
ROA
38.90%
|
EPS Growth
156.90%
|
Current Ratio
7.9
|
Debt/Equity
399.60%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Biostem Technologies Inc (BSEM) | $1.95 | - | - | 22M | Strong Buy |
| Lannett Company, Inc. (LCI) | $0.58 | - | - | 22.4M | Strong Buy |
| Clearside Biomedical Inc (CLSD) | $1.65 | - | - | 78.2M | Strong Buy |
| Assertio Holdings Inc (ASRT) | $2.73 | - | - | 136.8M | Strong Buy |
| Arbutus Biopharma Corp (ABUS) | $2.84 | - | - | 361.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
